Aurora Spine saw a 14.3% increase in its second-quarter revenue for 2024, reaching $4.02 million — up from $3.66 million year over year.
Here are four additional notes on Aurora Spine's second-quarter financial results, according to an Aug. 21 news release from the company:
1. The company's second quarter benefitted from a high demand in the pain management sector, specifically for the SiLO TFX and ZIP 51 implants.
2. The company's gross margins improved to 62.4% in the second quarter of 2024, up from 56.9% in the same period last year.
3. Operating expenses for the second quarter were $2.74 million, up from $2.51 million in 2023.
4. The Company reported a net loss of $(0.154) million for the quarter, narrowing from a net loss of $(0.482) million in 2023.